Tyrosine phosphorylation of both STAT5A and STAT5B is necessary for maximal IL-2 signaling and its mitogenic action
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接:
https://www.ncbi.nlm.nih.gov/sra/SRP470869
下载链接
链接失效反馈官方服务:
资源简介:
STAT5 proteins are vital for lymphocyte development and function. Cytokine activation of STAT5A and STAT5B involves the tyrosine phosphorylation of a C-terminal tyrosine in each protein; however, the importance of STAT5 tyrosine phosphorylation in vivo has not been assessed. Here we generated Stat5a and Stat5b tyrosine mutant knockin mice and found they had greatly reduced CD8+ T-cell numbers. Morever, these cells exhibited profoundly diminished IL-2-induced proliferation, correlating with reduced IL-2- mediated induction of Myc, pRB, a range of cyclins and CDKs, and a G1Ã S phase- transition block. The mutant CD8+ T cells also exhibited decreased IL-2-mediated activation of pERK and pAKT, which can in part be attributed to diminished IL-2-induced expression of IL-2Rb and IL-2Rg. Our findings demonstrate that tyrosine phosphorylation of both STAT5A and STAT5B is essential for maximal IL-2 signaling, and our transcriptomic and proteomic analyses elucidate the molecular basis for the mitogenic effects of IL-2 on CD8+ T cells. Overall design: ChIP-Seq and RNA-Seq analyses using freshly isolated mouse CD8+ T cells that were expanded with either no cytokine, or with IL-2 at various time points.
信号转导与转录激活因子5(STAT5)蛋白对于淋巴细胞的发育与功能至关重要。细胞因子介导的STAT5A与STAT5B激活,依赖于两种蛋白各自羧基末端酪氨酸位点的酪氨酸磷酸化修饰;然而,体内STAT5酪氨酸磷酸化的重要性尚未得到评估。本研究构建了Stat5a与Stat5b酪氨酸突变型敲入小鼠,发现其体内CD8阳性(CD8+)T细胞数量显著减少。此外,这些细胞的白细胞介素2(IL-2)诱导的增殖能力大幅受损,其与IL-2介导的原癌基因Myc、视网膜母细胞瘤蛋白(pRB)、多种细胞周期蛋白(cyclins)及细胞周期蛋白依赖性激酶(CDKs)的诱导表达下调相关,同时存在G1到S期的细胞周期阻滞。突变型CD8+ T细胞中,IL-2介导的磷酸化细胞外调节蛋白激酶(pERK)与磷酸化蛋白激酶B(pAKT)的激活水平也有所下降,这在一定程度上可归因于IL-2诱导的IL-2受体β链(IL-2Rβ)与IL-2受体γ链(IL-2Rγ)的表达下调。本研究结果证实,STAT5A与STAT5B的酪氨酸磷酸化对于实现最大化的IL-2信号转导至关重要;同时,我们的转录组学与蛋白质组学分析阐明了IL-2对CD8+ T细胞的促有丝分裂效应的分子机制。整体实验设计:使用新鲜分离的小鼠CD8+ T细胞进行染色质免疫沉淀测序(ChIP-Seq)与RNA测序(RNA-Seq)分析,这些细胞分别在无细胞因子或不同时间点的IL-2处理下进行扩增培养。
创建时间:
2024-10-01



